Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stephens

Showing results (951-960 of 1,072) with videos related to

Pageof 108
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinomaMarzia Capelletti, Michael E Dodge, Dalia Ercan, et al.
Chemical Communications (Cambridge, England)|December 3, 2019
Reaction-based indicator displacement assay (RIA) for the development of a triggered release system capable of biofilm inhibitionBethany L Patenall, George T Williams, Lauren Gwynne, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
Genome Medicine|May 31, 2013
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsMatthias Lechner, Garrett M Frampton, Tim Fenton, et al.
Oncotargets and Therapy|December 15, 2015
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapyCasey B Williams, Caitlin McMahon, Siraj M Ali, et al.
European Urology Focus|July 21, 2017
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy ResponseThai H Ho, Toni K Choueiri, Kai Wang, et al.
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
Journal of Clinical Pathology|August 1, 2014
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapiesJ S Ross, K Wang, J V Rand, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.
Pageof 108

Showing results (951-960 of 1,072) with videos related to

Sort By:
Pageof 108
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinomaMarzia Capelletti, Michael E Dodge, Dalia Ercan, et al.
Chemical Communications (Cambridge, England)|December 3, 2019
Reaction-based indicator displacement assay (RIA) for the development of a triggered release system capable of biofilm inhibitionBethany L Patenall, George T Williams, Lauren Gwynne, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
Genome Medicine|May 31, 2013
Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumorsMatthias Lechner, Garrett M Frampton, Tim Fenton, et al.
Oncotargets and Therapy|December 15, 2015
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapyCasey B Williams, Caitlin McMahon, Siraj M Ali, et al.
European Urology Focus|July 21, 2017
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy ResponseThai H Ho, Toni K Choueiri, Kai Wang, et al.
The Oncologist|March 16, 2018
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care TestingJames H Suh, Alexa B Schrock, Adrienne Johnson, et al.
Journal of Clinical Pathology|August 1, 2014
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapiesJ S Ross, K Wang, J V Rand, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2016
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to AfatinibSai-Hong Ignatius Ou, Alexa B Schrock, Eduard V Bocharov, et al.
Pageof 108